BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 29, 2006
View Archived Issues
Pfizer presents novel renin inhibitors at 231st ACS National Meeting
Read More
Johnson & Johnson profile their new 11beta-HSD1 inhibitor
Read More
DIN-106935: a mixed ion channel inhibitor
Read More
AMG-131: novel modulator of PPARgamma for type 2 diabetes
Read More
Two activators of ferric sGC from sanofi-aventis
Read More
Antiproliferative efficacy of BMS-554417, an IGF-IR inhibitor
Read More
Korean approval for Quinvaxem pentavalent vaccine
Read More
Eisai seeks Japanese approval for Pariet in nonerosive GERD
Read More
Draximage realigns R&D priorities
Read More
Immtech begins pivotal study of pafuramidine maleate
Read More
Idera secures funding to advance pipeline
Read More
Elixir acquires rights to Glufast
Read More
Geron signs agreements with U. of Oxford for dendritic cell production
Read More
FemmePharma opens IND for topical cream to treat breast pain
Read More
Chinese data support efficacy of telbivudine in chronic hepatitis B
Read More
Akzo Nobel updates pipeline status
Read More
SD's nano-emulsion paclitaxel formulation demonstrates efficacy in preclinical tests
Read More
Japanese cooperative marketing of Abbott and Dainippon Sumitomo comes to end
Read More
Lundbeck begins phase I trials for Lu-AA34893 for depression
Read More
Rituximab well tolerated, beneficial in steroid-refractory graft-versus-host disease
Read More
Recent patents disclose novel antiinfective agents
Read More
New treatments for hepatitis C described in recent patent literature
Read More
Additional treatment and switching therapy effective in treating resistant depression
Read More
New analgesic agents imparted in recent patents
Read More
New study data on 7-valent vaccination for invasive pneumococcal disease presented
Read More
Exelixis advances XL-784 into phase II for diabetic nephropathy
Read More
Levemir made available in U.S.
Read More